MIM
INSP icon

MetLife Investment Management’s Inspire Medical Systems INSP Stock Holding History

MetLife Investment Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90.9K Buy
1,762
+15
+0.9% +$1.05K ﹤0.01% 2578
2025
Q4 		$161K Sell
1,747
-84
-5% -$8.04K ﹤0.01% 2383
2025
Q3 		$136K Buy
1,831
+53
+3% +$5.37K ﹤0.01% 2515
2025
Q2 		$231K Sell
1,778
-23
-1% -$3.33K ﹤0.01% 2118
2025
Q1 		$287K Sell
1,801
-4
-0.2% -$724 ﹤0.01% 1997
2024
Q4 		$335K Sell
1,805
-41
-2% -$7.96K ﹤0.01% 2009
2024
Q3 		$390K Sell
1,846
-66
-3% -$11.5K ﹤0.01% 1917
2024
Q2 		$256K Buy
1,912
+140
+8% +$26.5K ﹤0.01% 2095
2024
Q1 		$381K Buy
1,772
+29
+2% +$5.68K ﹤0.01% 1823
2023
Q4 		$355K Sell
1,743
-24
-1% -$3.89K ﹤0.01% 1898
2023
Q3 		$351K Buy
1,767
+1
+0.1% +$252 ﹤0.01% 1844
2023
Q2 		$573K Sell
1,766
-13,227
-88% -$3.78M ﹤0.01% 1605
2023
Q1 		$3.51M Buy
14,993
+193
+1% +$48.8K 0.03% 653
2022
Q4 		$3.73M Sell
14,800
-152
-1% -$32.4K 0.03% 607
2022
Q3 		$2.65M Buy
14,952
+699
+5% +$140K 0.02% 749
2022
Q2 		$2.6M Sell
14,253
-176
-1% -$35.1K 0.02% 788
2022
Q1 		$3.7M Buy
14,429
+5,106
+55% +$1.17M 0.02% 713
2021
Q4 		$2.14M Hold
9,323
– – 0.02% 843
2021
Q3 		$2.17M Sell
9,323
-487
-5% -$102K 0.02% 827
2021
Q2 		$1.9M Hold
9,810
– – 0.02% 900
2021
Q1 		$2.03M Sell
9,810
-518
-5% -$110K 0.02% 862
2020
Q4 		$1.94M Sell
10,328
-569
-5% -$93K 0.02% 836
2020
Q3 		$1.41M Sell
10,897
-711
-6% -$78.3K 0.02% 880
2020
Q2 		$1.01M Buy
11,608
+6,049
+109% +$465K 0.01% 1031
2020
Q1 		$335K Sell
5,559
-1,279
-19% -$94.7K ﹤0.01% 1432
2019
Q4 		$507K Hold
6,838
– – 0.01% 1454
2019
Q3 		$417K Hold
6,838
– – ﹤0.01% 1523
2019
Q2 		$415K Hold
6,838
– – ﹤0.01% 1597
2019
Q1 		$388K Buy
6,838
+1,175
+21% +$63.5K ﹤0.01% 1604
2018
Q4 		$239K Buy
5,663
+2,749
+94% +$117K ﹤0.01% 1806
2018
Q3 		$123K Buy
+2,914
New +$137K ﹤0.01% 2332

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

MetLife Investment Management's INSP Position: Q1 2026 in Review

MetLife Investment Management increased its Inspire Medical Systems (INSP) stake by 0.86% in Q1 2026, buying an estimated $1.05K and bringing the position to 1,762 shares worth $90.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

MetLife Investment Management first reported a position in INSP in Q3 2018 and has held it in 31 quarters since. The position peaked at $3.73M in Q4 2022. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • MetLife Investment Management held 1,762 shares of Inspire Medical Systems worth $90.9K as of Q1 2026.
  • MetLife Investment Management bought 15 Inspire Medical Systems shares in Q1 2026, an estimated $1.05K.
  • Inspire Medical Systems made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2578 holding.
  • MetLife Investment Management first reported a position in Inspire Medical Systems in Q3 2018 and has held it in 31 quarters since.
  • MetLife Investment Management's Inspire Medical Systems position peaked at $3.73M in Q4 2022.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.